(OAKVILLE, Ontario) July 13, 2022 – Very pleased and proud to announce that our ForYOU Patient Support Program is up and actively supporting Canadian patients. Officially launched and enrolling patients in need as of July 4, with the first dispense of XPOVIO in combination with bortezomib and dexamethasone on July 11.
Congratulations to the FORUS and INNOMAR teams who made this happen on time and in the spirit of ensuring those that might benefit from this novel therapy have the opportunity to do so because “Patients Can’t Wait”.